117 related articles for article (PubMed ID: 8143276)
1. No rearrangements of the CHOP gene in malignant fibrous histiocytoma.
Nilbert M; Mandahl N; Aman P; Rydholm A; Mitelman F
Cancer Genet Cytogenet; 1994 Feb; 72(2):155-6. PubMed ID: 8143276
[TBL] [Abstract][Full Text] [Related]
2. Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11).
Aman P; Ron D; Mandahl N; Fioretos T; Heim S; Arheden K; Willén H; Rydholm A; Mitelman F
Genes Chromosomes Cancer; 1992 Nov; 5(4):278-85. PubMed ID: 1283316
[TBL] [Abstract][Full Text] [Related]
3. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma.
Kuroda M; Ishida T; Horiuchi H; Kida N; Uozaki H; Takeuchi H; Tsuji K; Imamura T; Mori S; Machinami R
Am J Pathol; 1995 Nov; 147(5):1221-7. PubMed ID: 7485386
[TBL] [Abstract][Full Text] [Related]
4. The 12q13-q15 translocation breakpoints in pleomorphic adenoma and clear-cell sarcoma of tendons and aponeuroses are different from that in myxoid liposarcoma.
Stenman G; Sahlin P; Mark J; Chaganti RS; Kindblom LG; Aman P
Genes Chromosomes Cancer; 1993 Jul; 7(3):178-80. PubMed ID: 7687873
[TBL] [Abstract][Full Text] [Related]
5. FUS/TLS-CHOP chimeric transcripts in liposarcoma tissues.
Yang X; Nagasaki K; Egawa S; Maruyama K; Futami H; Tsukada T; Yokoyama R; Beppu Y; Fukuma H; Shimoda T
Jpn J Clin Oncol; 1995 Dec; 25(6):234-9. PubMed ID: 8523819
[TBL] [Abstract][Full Text] [Related]
6. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.
Crozat A; Aman P; Mandahl N; Ron D
Nature; 1993 Jun; 363(6430):640-4. PubMed ID: 8510758
[TBL] [Abstract][Full Text] [Related]
7. Analysis of FUS-CHOP fusion transcripts in different types of soft tissue liposarcoma and their diagnostic implications.
Willeke F; Ridder R; Mechtersheimer G; Schwarzbach M; Duwe A; Weitz J; Lehnert T; Herfarth C; von Knebel Doeberitz M
Clin Cancer Res; 1998 Jul; 4(7):1779-84. PubMed ID: 9676855
[TBL] [Abstract][Full Text] [Related]
8. Fusion of the EWS and CHOP genes in myxoid liposarcoma.
Panagopoulos I; Höglund M; Mertens F; Mandahl N; Mitelman F; Aman P
Oncogene; 1996 Feb; 12(3):489-94. PubMed ID: 8637704
[TBL] [Abstract][Full Text] [Related]
9. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.
Antonescu CR; Elahi A; Healey JH; Brennan MF; Lui MY; Lewis J; Jhanwar SC; Woodruff JM; Ladanyi M
Clin Cancer Res; 2000 Jul; 6(7):2788-93. PubMed ID: 10914725
[TBL] [Abstract][Full Text] [Related]
10. Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by a chromosomal translocation involving bands 12q13 and 16p11.
Waters BL; Panagopoulos I; Allen EF
Cancer Genet Cytogenet; 2000 Sep; 121(2):109-16. PubMed ID: 11063792
[TBL] [Abstract][Full Text] [Related]
11. TLS-CHOP target gene DOL54 expression in liposarcomas and malignant fibrous histiocytomas.
Domoto H; Hosaka T; Oikawa K; Ohbayashi T; Ishida T; Izumi M; Iwaya K; Toguchida J; Kuroda M; Mukai K
Pathol Int; 2002 Aug; 52(8):497-500. PubMed ID: 12366807
[TBL] [Abstract][Full Text] [Related]
12. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma.
Rabbitts TH; Forster A; Larson R; Nathan P
Nat Genet; 1993 Jun; 4(2):175-80. PubMed ID: 7503811
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation.
Kanoe H; Nakayama T; Hosaka T; Murakami H; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Ron D; Sasaki MS; Toguchida J
Oncogene; 1999 Jan; 18(3):721-9. PubMed ID: 9989822
[TBL] [Abstract][Full Text] [Related]
14. Translocations and amplifications of chromosome 12 in liposarcoma demonstrated by the LSI CHOP breakapart rearrangement probe.
Willmore-Payne C; Holden J; Turner KC; Proia A; Layfield LJ
Arch Pathol Lab Med; 2008 Jun; 132(6):952-7. PubMed ID: 18517278
[TBL] [Abstract][Full Text] [Related]
15. Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia.
Panagopoulos I; Lassen C; Isaksson M; Mitelman F; Mandahl N; Aman P
Oncogene; 1997 Sep; 15(11):1357-62. PubMed ID: 9315104
[TBL] [Abstract][Full Text] [Related]
16. Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features.
Dal Cin P; Sciot R; Panagopoulos I; Aman P; Samson I; Mandahl N; Mitelman F; Van den Berghe H; Fletcher CD
J Pathol; 1997 Aug; 182(4):437-41. PubMed ID: 9306965
[TBL] [Abstract][Full Text] [Related]
17. Genomic PCR detects tumor cells in peripheral blood from patients with myxoid liposarcoma.
Panagopoulos I; Aman P; Mertens F; Mandahl N; Rydholm A; Bauer HF; Mitelman F
Genes Chromosomes Cancer; 1996 Oct; 17(2):102-7. PubMed ID: 8913727
[TBL] [Abstract][Full Text] [Related]
18. The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas.
Forus A; Flørenes VA; Maelandsmo GM; Fodstad O; Myklebost O
Cancer Genet Cytogenet; 1994 Dec; 78(2):165-71. PubMed ID: 7828148
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein.
Kuroda M; Ishida T; Takanashi M; Satoh M; Machinami R; Watanabe T
Am J Pathol; 1997 Sep; 151(3):735-44. PubMed ID: 9284822
[TBL] [Abstract][Full Text] [Related]
20. Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas.
Antonescu CR; Elahi A; Humphrey M; Lui MY; Healey JH; Brennan MF; Woodruff JM; Jhanwar SC; Ladanyi M
J Mol Diagn; 2000 Aug; 2(3):132-8. PubMed ID: 11229517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
